Immune cells within tertiary lymphoid structures are associated with progression-free survival in patients with locoregional recurrent breast cancer.
Gu J, Wang J, Sun Y, Mao X, Qian C, Tang X, Wang J, Xie H, Ling L, Zhao Y, Liu X, Zhang K, Pan H, Wang S, Wang C, Zhou W.
Gu J, et al. Among authors: wang j, wang s, wang c.
Cancer Med. 2023 Dec 22;13(1):e6864. doi: 10.1002/cam4.6864. Online ahead of print.
Cancer Med. 2023.
PMID: 38133211
Free PMC article.